Impact of Endorectal Balloon in the Dosimetry of Prostate and Surrounding Tissues in Prostate Cancer Patients Treated with IMRT

Medical Dosimetry

Volumn 32, Issue 4, 2007, Pages 281-286

  Vlachaki, Maria T ^a   Teslow, Terrance N ^b   Ahmad, Salahuddin ^c  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Endorectal balloon; IMRT; Prostate cancer; Prostate immobilization

Indexed keywords

ADULT; ARTICLE; BALLOON CATHETER; CLINICAL ARTICLE; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DOSIMETRY; FUNCTIONAL ANATOMY; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROSTATE CANCER; SEMINAL VESICLE; SIMULATION; TREATMENT PLANNING;

BALLOON DILATATION; HUMANS; IMMOBILIZATION; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35548930321     PISSN: 09583947     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meddos.2007.02.007     Document Type: Article

References (36)

1. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 41 (1998) 491-500
2. Kupelian P.A., Buchsbaum J.C., Reddy C.A., et al. Radiation dose response in patients with favorable localized prostate cancer (Stage T1-T2, biopsy Gleason < or = 6 and pretreatment prostate-specific antigen < or = 10). Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 621-625
3. Hanks G.E., Martz K.L., and Diamond J.J. The effect of dose on local control of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 15 (1988) 1299-1305
4. Pollack A., Zagars G.K., Starkschall G., et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 53 (2002) 1097-1105
5. Storey M.R., Pollack A., Zagars G.K., et al. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 635-642
6. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 685-698
7. Ten Haken R.K., Forman J.D., Heimburger D.K., et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int. J. Radiat. Oncol. Biol. Phys. 20 (1991) 1317-1324
8. Roeske J.C., Forman J.D., Mesina C.F., et al. Evaluation of changes in the size and location of the prostate, seminal vesicles, bladder, and rectum during a course of external beam radiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 33 (1995) 1321-1329
9. Schild S.E., Casale H.E., Bellefontaine L.P., et al. Movements of the prostate due to rectal and bladder distension: Implications for radiotherapy. Med. Dosim. 18 (1993) 13-15
10. Padhani A.R., Khoo V.S., Suckling J., et al. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI. Int. J. Radiat. Oncol. Biol. Phys. 44 (1999) 525-533
11. Langen K.M., and Jones D.T.L. Organ motion and its management. Int. J. Radiat. Oncol. Biol. Phys. 50 (2001) 265-278
12. Antolak J.A., Rosen I.I., Childress C.H., et al. Prostate target volumes variations during a course of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 42 (1998) 661-672
13. Roach III M., Faillace-Akazawa P., and Malfatti C. Prostate volumes and organ movement defined by serial computerized tomographic scans during three-dimensional conformal radiotherapy. Radiat. Oncol. Invest. 5 (1997) 187-194
14. Lattanzi J., McNeeley S., Pinover W., et al. A comparison of daily CT localization to a daily ultrasound-based system in prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 43 (1999) 719-725
15. Lattanzi J., McNeeley S., Donnelly S., et al. Ultrasound-based stereotactic guidance in prostate cancer-quantification of organ motion and set-up errors in external beam radiation therapy. Comput. Aid. Surg. 5 (2000) 289-295
16. Vigneault E., Pouliot J., Lavadiere J., et al. Electronic portal imaging device detection of radiopaque markers for the evaluation of prostate position during megavoltage irradiation: A clinical study. Int. J. Radiat. Oncol. Biol. Phys. 37 (1997) 205-212
17. Shimizu S., Shirato H., Kitamura K., et al. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 1591-1597
18. Mohan D.S., Kupelian P.A., and Willoughby T.R. Short-course intensity-modulated radiotherapy for localized prostate cancer with daily transabdominal ultrasound localization of the prostate gland. Int. J. Radiat. Oncol. Biol. Phys. 46 (2000) 575-580
19. Teh B.S., Woo S.Y., Mai W.Y., et al. Clinical experience with intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of rectal balloon for prostate immobilization. Med. Dosim. 27 (2002) 105-113
20. McGary J.E., Teh B.S., Butler E.B., et al. Prostate immobilization using a rectal balloon. J. Appl. Clin. Med. Phys. 3 (2002) 6-11
21. Teh B.S., Dong L., McGary J.E., et al. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity modulated radiation therapy (IMRT) for prostate cancer. Med. Dosim. 30 (2005) 25-30
22. Carol M.P. Beam modulation conformal radiotherapy. In: Purdy J.A., and Emami B. (Eds). 3D Radiation Treatment Planning and Conformal Therapy (1993), Advanced Medical Publishing, Madison, WI 435-445
23. Grant III W.H. Experience with intensity modulated beam delivery. In: Mackie T.R., and Palta J.R. (Eds). Teletherapy: Present and Future (1996), Advanced Medical Publishing, Madison, WI 793-804
24. Sternick E.S., Carol M.P., and Grant III W.H. Intensity modulated radiotherapy. In: Khan F.M., and Potish R.A. (Eds). Treatment Planning in Radiation Oncology (1998), Williams and Wilkins, Baltimore 187-213
25. McGary J.E., and Grant III W.H. A clinical evaluation of set-up errors for a prostate immobilization system. J. Appl. Clin. Med. Phys. 1 (2000) 138-147
26. Ahmad S., Vlachaki M.T., Teslow T.N., et al. Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with Peacock/IMRT. Med. Dosim. 30 (2005) 1-7
27. Ahmad S., Vlachaki M.T., et al. Impact of margin on tumor and normal tissue dosimetry in prostate cancer patients treated with IMRT using an endorectal balloon for prostate immobilization. Austral. Phys. Eng. Sci. Med. 28 (2005) 209-215
28. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: Acute toxicity and dose-volume analysis. Int. J. Radiat. Oncol. Biol. Phys. 49 (2001) 705-712
29. Sanghani M., Ching J., Schultz D., et al. Impact on rectal dose from the use of a prostate immobilization and rectal localization device for patients receiving dose escalated 3D conformal radiation therapy. Urol. Oncol. 22 (2004) 165-168
30. Wachter S., Gerstner N., Dorner D., et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 52 (2002) 91-100
31. Patel R., Orton N., Tome W., et al. Rectal dose sparing with a balloon catheter and ultrasound localization in conformal radiation therapy for prostate cancer. Radiother. Oncol. 65 (2003) 285-294
32. Teh B.S., Bastasch M.D., Wheeler T.M., et al. IMRT for prostate cancer defining target volume based on correlated pathologic volume of disease. Int. J. Radiat. Oncol. Biol. Phys. 56 (2003) 184-191
33. Diaz A.Z., Roach M., Marquez C., et al. Indications for and significance of including the seminal vesicles during 3D conformal radiotherapy in men with clinically localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 30 (1996) 323
34. Marks L.B., Carroll P.R., Dugan T.C., et al. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31 (1995) 1257-1280
35. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and then European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 31 (1995) 1341-1346
36. Wachter S., Gerstner N., Goldner G., et al. Rectal sequelae after conformal radiotherapy of prostate cancer: Dose-volume histograms as predictive factors. Radiother. Oncol. 59 (2001) 65-70